Status: Not yet recruiting
Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Treated With Cesium-131 GammaTile®
This is a phase 2, open-label clinical trial determining feasibility, safety, and tolerability of GammaTile® in elderly or frail subjects with newly diagnosed or recurrent malignant gliomas.
Participants needed: 20
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University of California, IrvineUpdated: Sep 23, 2026Locations: 1
Eligibility criteria
Supratentorial [+9]
Staged surgery planned (prior biopsy allowed). [+5]